Cochlear Limited Appoints Michael Daniell to the Board

  • Dec 10, 2019 AEDT
  • Team Kalkine

Cochlear Limited (ASX: COH) has appointed highly experienced Michael Daniell to the Cochlear Board, effective from 1 January 2020.

Mr Daniell has worked in the medical device industry for 40 years and has extensive executive leadership experience. Mr Daniell is currently serving as Non-Executive Director of Fisher & Paykel Healthcare.

He would be a Non-Executive Director and is considered by the Board to be independent.

At AEST 01:07 PM, the stock was trading at $228.230, down by 1.032% from the previous close.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK